More than 50 clinical trials were approved in the first quarter of this year, with over 80 percent led by overseas entities, data showed Tuesday.
The Korean bioindustry's output surged more than 20 percent in 2021 from a year earlier on the back of brisk exports amid the coronavirus pandemic, data showed Thursday
Korea JoongAng Daily Sitemap
